← Special Briefings Global Supply Chain Risk Assessment
AI-Generated Content — May Contain Errors — Not Independently Fact-Checked — Research Use Only
Executive Summary Audio Overview Key Statistics Dominance Chart Rare Earths Semiconductors Pharmaceuticals Energy & Batteries Defense Industrial Base Maritime Chokepoints Disruption Timeline Reshoring Progress Severity Matrix Methodology

Executive Summary

The global supply chain architecture has transitioned from an era of frictionless globalization to one of structural volatility and geopolitical weaponization. At the center of this fragility is China, which controls not merely raw material extraction but the far more strategically critical processing, refining, and mid-stream manufacturing stages across virtually every critical sector. China refines 91% of global rare earths, manufactures 94% of high-performance permanent magnets, processes 85–97% of battery materials by stage, and supplies over 80% of the key starting materials for global pharmaceutical production. Cross-Verified

A complete supply chain severance — whether triggered by a Taiwan Strait conflict, maximalist trade war, or cascading export controls — would produce the most severe economic disruption in modern history. Bloomberg Economics estimates a Taiwan conflict scenario alone would cost $10.6 trillion globally in the first year. Within 30 days, automotive and electronics manufacturing would halt. Within 90 days, pharmaceutical shortages would require government rationing. Within a year, cumulative GDP losses would reach 5–10%, with recovery timelines measured in decades, not years. The window for building alternative supply chains is closing: China’s temporarily suspended export controls can be reactivated at any time, and the 10–15 year timelines required to rebuild domestic processing mean every year of delay compounds the strategic risk. Forecast

Audio Overview: China’s Monopoly on Critical Material Refining

AI-generated audio summary of the Gemini deep research report on systemic supply chain risks and China’s processing dominance across rare earths, semiconductors, pharmaceuticals, and energy materials.

Key Statistics at a Glance

91% China’s REE Refining Share
94% NdFeB Magnet Production
90%+ Advanced Chips (Taiwan)
80%+ Pharma KSMs from China
99% Gallium (China)
85% Battery Anodes (China)
$10.6T Taiwan Conflict Cost (Yr 1)
232:1 China vs US Shipbuilding

China’s Supply Chain Dominance by Sector

Source: USGS Mineral Commodity Summaries 2026, IEA Critical Minerals 2025, EIA Battery Supply Chain Analysis. Figures represent processing/refining share, not mining.

Rare Earth Elements: The Invisible Foundation

Why Processing Matters More Than Mining

A recurring misconception is that mineral extraction equals supply chain dominance. In reality, geopolitical leverage lies in processing and refinement. While rare earth ores are distributed globally (China, US, Australia, Myanmar, Africa), China controls the critical mid-stream stages through decades of state-subsidized capital expenditure and proprietary metallurgical expertise. The DOE documents that China’s share rises from ~58% of global mining to ~92% of magnet alloy manufacturing. Cross-Verified

The supply chain for the seventeen rare earth elements is bifurcated between “light” and “heavy” elements. While light REE extraction has seen some diversification, China maintains near-absolute dominance over heavy REE refining — controlling approximately 92–99% of global capacity depending on the specific element. Cross-Verified [CSIS]

Military dependency is absolute: A single F-35 fighter requires 920 pounds of rare earth elements (CRS, 2013). An Arleigh Burke-class destroyer needs 5,200 pounds. A Virginia-class submarine requires approximately 9,200 pounds. The US possesses zero commercial-scale heavy REE separation capacity. Cross-Verified [Heritage Foundation]

Rare Earth Supply Chain Flow

Rare Earth Element Processing Pipeline — Chokepoint Analysis

Mining & Extraction
Global (diversifying)
Roasting & Cracking
China concentrated
Solvent Extraction
China 92–99%
Metal Reduction
China 91%
Magnet Fabrication
China 94%
End-Use Integration
US, EU, Japan, Korea

Weaponization Through Export Controls

Beijing has codified its leverage through legal frameworks including the updated Dual-Use Export Control List. Starting in August 2023, China escalated export restrictions on gallium, germanium, and antimony. By December 2024, outright bans targeted exports to the United States (MOFCOM Notice 2024 No. 46). In April 2025, controls expanded to seven medium-heavy rare earths, and by October 2025, restrictions covered rare earth processing equipment and technologies — the first application of a “foreign direct product rule” to minerals. Cross-Verified [LSE]

Though most restrictions were suspended through late 2026 following a bilateral agreement, the legal architecture remains intact and military end-use bans remain in force. Reactivation is possible within hours. Analytical Assessment

US import reliance and China’s production share for key critical minerals. Source: USGS Mineral Commodity Summaries 2025/2026.

Semiconductors: The Taiwan Concentration Crisis

The Most Acute Single-Point Vulnerability

TSMC holds 64–71% of global foundry revenue (TrendForce Q1–Q3 2025) and produces approximately 90% of the world’s most advanced logic chips (sub-7nm). Taiwan accounts for over 60% of global foundry revenue. Every major US chip designer — Apple, Nvidia, AMD, Qualcomm — depends on TSMC fabrication. The US share of global chip manufacturing stands at roughly 12%. Cross-Verified

The Overlooked ATP Chokepoint

The most overlooked vulnerability is Assembly, Test, and Packaging (ATP). With the cessation of Moore’s Law scaling, the industry pivoted to “advanced packaging” (2.5D/3D integration, CoWoS, chiplets) for AI accelerators and 6G infrastructure. China holds 30% of the global ATP market and Taiwan 28%. Even if the US reshores front-end wafer fabrication through the CHIPS Act, those wafers must currently be shipped to Asia for packaging. Cross-Verified

China’s legacy chip offensive: Chinese foundries now command ~31% of global mature-node capacity (28nm+), projected to reach ~50% by 2029. China added more chipmaking capacity than the rest of the world combined in 2024 (Gavekal Dragonomics). USTR investigations allege Chinese chips are underpriced by 30–50% below production costs. Cross-Verified

Semiconductor Supply Chain — Concentration Risk

EDA & IP Design
USA 68%
Materials & Chemicals
Japan, Korea, Taiwan
Equipment (Litho)
USA 47%, Japan 26%
Wafer Fab (<5nm)
Taiwan 90%+
ATP (Packaging)
China 30%, Taiwan 28%

CHIPS Act Progress

TSMC Arizona’s Fab 1 began 4nm production in late 2024 — the first leading-edge chips on US soil. TSMC expanded its Arizona commitment to $165+ billion for six fabs, two advanced packaging plants, and an R&D center (March 2025 press release). The CHIPS Act has catalyzed over $540 billion in announced private investment across 100+ projects (SIA). However, Intel’s Ohio megafab has slipped 5–6 years to 2030–2031. Samsung Taylor lacks customer orders for equipment installation. Cross-Verified

Pharmaceuticals: The Hidden Life-or-Death Dependency

The Key Starting Material Illusion

The pharmaceutical supply chain presents a direct, immediate threat to civilian populations. Over 90% of prescriptions dispensed in the US are generic drugs. India is often cited as a diversification success, supplying 47% of US generics. But this obscures a deeper vulnerability: India relies on China for approximately 70% of its Active Pharmaceutical Ingredients, and for critical antibiotics the dependence approaches 90%. Cross-Verified [DrugPatentWatch]

The deepest vulnerability lies upstream in Key Starting Materials (KSMs) — foundational chemicals needed to synthesize APIs. KSM synthesis involves highly polluting chemistry that Western environmental regulations effectively exiled from the US and EU over two decades. The USP Medicine Supply Map found 41% of all KSMs used in US-approved APIs are sole-sourced from China. Cross-Verified [USP Quality Matters]

Life-critical concentrations: Analysis shows China holds sole-source KSM dominance for 100% of Angiotensin II Receptor Blockers (ARBs), 94% of blood glucose drugs, 83% of direct-acting antivirals, and 71% of antineoplastics (chemotherapy). Meanwhile, 70.1% of US antibiotic API imports by volume came from China in 2024 (PMC/CIDRAP), with 92% of imported penicillin and streptomycin APIs from Chinese sources. Cross-Verified [USP]

Note on pharmaceutical data nuance: The commonly cited figure that “80% of APIs come from China” overstates direct dependency. Brookings research finds Chinese-produced APIs appear in roughly a quarter of US generic drug unit volume when measured at the finished-dose level. The much higher figures (70–80%) emerge when measuring upstream KSM dependency and India’s secondary reliance on Chinese inputs. Both perspectives are valid — they measure different stages of the same supply chain. Methodological Note

Generic Pharmaceutical Supply Chain — Upstream Vulnerability

Chemical Feedstocks
China, Global
Key Starting Materials
China 41% sole-source
Active Pharma Ingredients
China + India (70% dependent)
Formulation (FDF)
India 47%, USA, EU
Distribution
US wholesalers

The Department of Defense’s own Section 860 assessment found that 54% of its pharmaceutical supply chain is high or very high risk, with 27% of drugs on the FDA’s Essential Medicines List categorized as “Very High Risk” due to Chinese sourcing. Heparin, administered to approximately 12 million hospitalized Americans annually for surgeries and dialysis, relies on Chinese porcine intestines for ~60% of crude supply. Cross-Verified

Energy Transition: Near-Total Chinese Control

Battery Materials

China’s CATL holds 39.2% of global EV battery installations (CnEVPost, full-year 2025), with BYD at ~16.4%. Chinese manufacturers collectively control approximately 60–65% of the global EV battery market. At the material level, China processes 85% of anodes, 82% of electrolytes, 74% of separators, and 70% of cathodes (EIA, 2022 data). For battery-grade graphite, Chinese dominance reaches 93–99% depending on the processing stage. The US produced zero natural graphite in 2024. Cross-Verified

Solar PV Manufacturing

China’s solar dominance is the most extreme of any supply chain. It controls over 80% of polysilicon, ~95–98% of ingots and wafers, ~80–92% of cells, and ~75–85% of modules (IEA, Renewable Energy Institute). US solar module capacity has surged past 51 GW thanks to IRA incentives, but this capacity overwhelmingly assembles imported components. Only First Solar, using cadmium telluride thin-film technology that bypasses the Chinese crystalline silicon chain, represents genuine domestic independence with ~14 GW of US capacity. Cross-Verified

The Cobalt Nexus

Approximately 73–77% of global cobalt ore is extracted in the Democratic Republic of Congo (USGS, 2025). Chinese entities control a significant share of DRC mining output, and China is the world’s leading producer of refined cobalt (USGS). This creates compounded risk: vulnerable to both DRC political instability and PRC export controls. Cross-Verified

Nuclear Fuel

Russia controls ~40–44% of global uranium enrichment capacity and supplied ~25% of enriched uranium for US reactors in 2024. For HALEU needed by next-generation reactors, Russia remains the sole commercial supplier globally. Congress appropriated $2.72 billion for domestic enrichment, but new centrifuge facilities require 7–10 years from design to operation. Cross-Verified

China’s control of the clean energy supply chain by manufacturing stage. Source: EIA 2022, IEA 2025.

Defense Industrial Base: Structural Fragility

The Shipbuilding Asymmetry

China’s shipbuilding capacity exceeds America’s by a factor of 232 to 1 (ONI). In 2024, China built over 1,000 commercial vessels; the US built 8. The PLAN now operates 370+ warships versus the US Navy’s ~296 battle force ships, projected to shrink to ~283 by 2027. US submarine production has collapsed to ~1.1–1.2 boats per year against a target of 2.0, with 17 Virginia-class submarines in backlog and approximately 40% of the fast-attack submarine fleet inoperable due to maintenance delays (Bloomberg, July 2023). Cross-Verified

Weapons Systems at Risk

A Govini analysis found that 9.3% of Tier 1 subcontractors to US defense primes are Chinese firms, spanning 1,900 weapon systems with over 80,000 Chinese-controlled components — affecting 78% of US military weapon systems. The US Navy is most exposed, with over 91% of systems requiring at least one Chinese-controlled critical mineral. Cross-Verified [Heritage Foundation]

All 825+ F-35s produced contain components from Chinese-origin cobalt-samarium alloy — a fact discovered only in September 2022 when Pentagon found a Honeywell subcontractor had been sourcing from China since 2003 (~19 years), at the fifth tier of the supply chain. Cross-Verified

Drone dependency: DJI commands ~70–80% of the global commercial drone market and up to 90% among US public safety agencies. The FCC added DJI to its “Covered List” in December 2025, creating an immediate capability gap. 43% of commercial operators reported “extremely negative” impacts. Most drones cleared through DOD’s Blue UAS program still have motors sourced from China. Cross-Verified

920 lbs REEs per F-35
9,200 lbs REEs per Virginia-class Sub
1 week Missile stockpile depletion (CSIS war game)
78% Weapons systems with Chinese components

Maritime Chokepoints: Where Trade Meets Geography

Seven maritime chokepoints concentrate global trade vulnerability. The Strait of Malacca carries 24–30% of all global seaborne trade. The Taiwan Strait facilitates $2.45 trillion in annual trade (CSIS). A Nature Communications study estimates ~20% of global maritime trade value passes through the Taiwan Strait and Malacca Strait combined. The Strait of Hormuz handles 34% of global seaborne oil exports. As of March 2026, the active Iran conflict has disrupted Hormuz traffic, compounding Houthi disruptions at Bab el-Mandeb that reduced Suez Canal transits by over 70% in 2024. Cross-Verified

China’s Belt and Road Initiative has established dual-use ports from the South China Sea through the Indian Ocean to the Middle East. ZPMC, a DOD-designated Chinese military company, manufactures ~80% of ship-to-shore cranes at US ports, with Congressional investigations discovering unauthorized cellular modems that could bypass port firewalls. China also manufactures 96% of shipping containers used at US ports. Cross-Verified

Global maritime chokepoints and their annual trade volumes. Red markers indicate active disruption as of March 2026.

Disruption Scenario: Complete Supply Chain Severance

Based on modeling from Bloomberg Economics, RAND, CSIS, and the IMF, a complete China–US supply chain severance would unfold in accelerating phases. All three source reports converge on remarkably consistent timelines: Multi-Source Synthesis

Days 1–15: Financial Shock & Inventory Buffer

Financial markets crash 15–25% in technology indices. Existing inventory buffers shield most physical shortages. Panic buying begins for electronics and pharmaceuticals. War risk insurance premiums surge, freezing merchant shipping in the Indo-Pacific. Inbound Asian traffic at US West Coast ports plunges 50–63%.

Days 15–30: Industrial Shutdown Begins

Auto industry executives warned that within three weeks, the US automotive industry would shut down. PCB and passive component supplies deplete. Pharmaceutical shortages emerge for sole-source Chinese APIs (66 molecules have factories only in China). Solar panel installation halts. Critical mineral prices spike dramatically on spot markets. GDP drag: 0.5–1.0% annualized.

Days 30–60: Cascading Industrial Collapse

EV production stops entirely. Battery material shortages halt grid storage deployment. Drug shortages expand to common antibiotics. The 2021 semiconductor shortage cost $210 billion (AlixPartners revised estimate) and 11 million vehicles — a full cutoff would be orders of magnitude worse. GDP impact: 1.5–3.0% annualized.

Days 60–90: Systemic Crisis

Job losses reach 2–4 million. Consumer prices spike 10–20%. Medical device and pharmaceutical shortages require government rationing. Ammunition production constrained by antimony shortages. F-35 production slows. Indian pharmaceutical production falters due to its own 65–70% Chinese API dependency. GDP decline: 3–5% annualized.

Days 90–180: Deep Recession & Military Sustainment Crisis

GDP decline of 5–7%. Unemployment reaches 5–8 million. Emergency Defense Production Act invocations. Digital infrastructure degrades as server replacements become unavailable. Energy transition halts — solar PV and wind turbine deployment drops 80%+. DoD faces critical sustainment crisis: spare parts for precision-guided munitions are cut off.

Days 180–365: Structural Damage & Hysteresis

Cumulative GDP loss of 5–10%, or $1.5–2.5 trillion. Structural unemployment of 3–6 million. Sustained inflation of 6–12%. Alternative suppliers begin ramping but capacity is severely limited. The global economy enters structural recession.

Beyond 1 Year: Permanent Capacity Loss

The IMF estimates full decoupling would reduce global GDP by ~7% ($7.4 trillion). Recovery timelines: rare earth processing 10–15 years, semiconductor self-sufficiency $1 trillion+ and 7–10 years, pharmaceutical API independence 5–10 years, shipbuilding capacity 15–20 years. SIA/BCG estimate semiconductor self-sufficiency alone would raise chip prices 35–65%.

Modeled GDP impact trajectory of a complete China–US supply chain severance. Based on Bloomberg Economics, RAND, and IMF estimates.

Reshoring Reality: Progress, Gaps, and Timelines

Where Progress Is Real

The US government has committed over $500 billion in federal incentives across the CHIPS Act, IRA, DPA invocations, and defense investments. Private sector semiconductor announcements exceed $540 billion (by December 2025, over $630 billion across 140+ projects). Genuine progress exists:

  • TSMC Arizona — 4nm production operational, yields reportedly 4% higher than Taiwan fabs. Expanded to $165+ billion commitment for six fabs. Largest single FDI in US history.
  • MP Materials — Commercial NdPr metal production at Fort Worth, first US rare earth metal in decades. DOD took 15% equity stake with $400 million funding.
  • Tesla Corpus Christi — North America’s first spodumene-to-lithium-hydroxide refinery (operational January 2026).
  • US Solar Module Capacity — Surged past 51 GW (190% increase from IRA incentives).

Where Gaps Persist

  • Intel Ohio — Slipped 5–6 years to 2030–2031 (announced February 2025)
  • Lynas Texas heavy rare earth facility — “might not proceed” under current conditions, leaving US without domestic dysprosium or terbium processing
  • Pharma API reshoring — largely aspirational; minimal equipment procurement uptick through Q2 2025
  • Kearney Reshoring Index — fell 311 basis points into negative territory (2023–2024), first decline since 2021
  • Workforce gap — projected 2.1 million unfilled manufacturing jobs by 2030; ~500,000 currently vacant

The workforce constraint is the binding bottleneck. Shipyard workers require 10–15 years for full proficiency. Semiconductor technicians take 3–5 years. 27% of the US maritime workforce is aged 55+. Policy whiplash between administrations further undermines confidence — Q1 2025 saw $6.9 billion in clean manufacturing project cancellations, the highest quarterly value on record. Cross-Verified

Full decoupling is not economically feasible. SIA and BCG estimate semiconductor self-sufficiency alone would require $1 trillion upfront plus $45–125 billion per year in recurring costs, raising chip prices 35–65%. The practical approach is selective “derisking” of the most critical supply chains while maintaining broader trade. Cross-Verified [CSIS]

Estimated years to achieve meaningful domestic capacity across critical supply chains.

Severity Matrix: All Major Supply Chains

Synthesized from all three deep research reports. Severity ratings reflect China/adversary control level, onset speed, recovery timeline, and cascading impact potential. Multi-Source Synthesis

Supply Chain Severity China/Adversary Control Onset Speed Recovery Time
Rare Earth Processing/Magnets 9.2/10 91% refining, 94% magnets Days 10–15 years
Advanced Semiconductors 8.8/10 90%+ (Taiwan/TSMC) Weeks 7–10 years
Battery Materials & Cells 8.5/10 70–97% by stage 30–60 days 5–8 years
Drones & UAV Components 8.0/10 70–90% market Immediate 3–5 years
Pharmaceutical APIs 7.8/10 ~25% direct, 80%+ upstream KSMs 30–90 days 5–10 years
PCBs & Passive Electronics 7.8/10 50–60% of PCBs 15–30 days 3–5 years
Legacy Semiconductors 7.5/10 31%, growing to 50% 2–4 weeks 3–5 years
Critical Minerals (Ga, Ge, Sb) 7.2/10 85–99% by mineral Immediate 5–10 years
Solar Components 7.0/10 80–98% by stage Immediate 5–10 years
Medical Devices & PPE 6.5/10 60–70% imported 15–30 days 2–5 years
Fertilizers 6.0/10 Variable; potash 33% Russia+Belarus 90–180 days 3–5 years
Telecom Equipment 5.8/10 42–55% (Huawei+ZTE globally) 60–120 days 3–5 years
Shipbuilding Capacity 5.5/10 232:1 gap Months–years 15–20 years
Steel & Aluminum 5.0/10 US 87% self-sufficient (steel) 60–90 days 2–5 years

Additional Single-Point Vulnerabilities

Titanium sponge — zero US production, China 69% global share. Magnesium — sole US producer (US Magnesium) filed for bankruptcy September 2025, China 85%. Manganese — 100% US import reliance, China 85% of high-purity refining. Chromium — 100% import reliance. Graphite for battery anodes — 93–99% Chinese processing. Cross-Verified

Cascading Effects: How Small Disruptions Become Systemic

The severity of a supply chain cutoff is amplified by deep interconnections across seemingly unrelated sectors. Modeling second- and third-order effects consistently reveals impacts 2–3 times larger than first-order estimates suggest. Analytical Assessment

Gallium → E-Commerce: Gallium cutoff halts advanced RF chips and optical transceivers → 5G and data center expansion stops → cloud computing and AI growth constrained → SaaS platforms and logistics networks degrade.

Rare Earths → Food Security: REE cutoff halts NdFeB magnet production → agricultural equipment manufacturing stops → existing machinery degrades without spare parts → crop yields decline → global food price increases.

Pharmaceuticals → Workforce: KSM shortages halt generic drug production → chronic medication shortages → deteriorating public health → increased absenteeism → shrinking labor force → productivity drag on economic recovery.

Rare Earths → Clean Energy → Fossil Fuels: REE cutoff halts EV manufacturing → reduces battery demand → undermines business case for domestic lithium refining → delays clean energy transition → increases fossil fuel dependency. A single supply chain break can cascade into self-reinforcing negative cycles.

Interconnected supply chain dependencies showing how a disruption in one sector cascades through the economy.

Source Methodology & Verification Notes

Multi-Source Synthesis Approach

This assessment synthesizes three independent deep research reports generated by different AI systems (Claude Opus 4.6, ChatGPT Deep Research, and Google Gemini Deep Research), each drawing on distinct source pools. Claims that appear consistently across all three reports and are traceable to authoritative primary sources (USGS, IEA, EIA, GAO, CSIS, DOE, DOD) are marked “Cross-Verified.”

Primary government sources cited across reports: USGS Mineral Commodity Summaries 2025/2026, IEA Global Critical Minerals Outlook 2025, EIA Battery Supply Chain Analysis, GAO Defense Industrial Base reports (GAO-24-107176, GAO-25-107283), DOE Rare Earth Magnet Supply Chain assessments, CSIS strategic analyses, Bloomberg Economics modeling, SIA/BCG semiconductor reports.

Automated Fact-Check Results

Each source document was independently fact-checked by a verification agent. Results:

  • Claude Opus report: 27/31 key claims verified (92% accuracy). 4 minor disputes (heparin patient count, BYD market share timing, Navy ship count). Zero fabricated claims.
  • ChatGPT Deep Research: 26/29 claims verified (90%). Most rigorously sourced of the three, with best pharmaceutical nuance. 2 minor inaccuracies (antimony import reliance, DRC cobalt share).
  • Gemini Deep Research: 13/17 key claims verified. 2 inaccuracies: GDP fragmentation estimate misattributed to OECD (should be IMF), graphite refining share overstated as “nearly 100%” (actual: 93–99%). One questionable “DENTY” acronym that includes neodymium (a light REE) in a heavy REE grouping.

Known Data Discrepancies Between Reports

Where reports cite different figures for the same metric, this page presents verified ranges rather than single figures. The most significant discrepancy is in pharmaceutical dependency: Brookings research finds ~25% of generic drug unit volume directly traceable to Chinese APIs, while upstream KSM analysis shows 41% sole-sourced from China and India’s 70% API dependency on China pushes effective exposure much higher. Both measurements are valid at different supply chain stages.

Limitations: All three source reports were generated by AI systems and may contain errors. Source links have been spot-checked (39/48 Gemini URLs confirmed working, all 8 ChatGPT primary sources confirmed). Figures should be independently verified against primary government databases before citation in policy contexts.